Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.53 EUR
−392.16 M EUR
0.00 EUR
About CEREVEL THERAPEUTICS HOLDINGS INC
Sector
CEO
Ronald C. Renaud
Headquarters
Cambridge
Website
Founded
2018
FIGI
BBG01BV0JYC1
Cerevel Therapeutics Holdings, Inc. engages in the discovery and development of new therapies for neuroscience diseases. The firm's portfolio focuses on diseases such as schizophrenia, epilepsy, and Parkinson's disease. Its product candidates include CVL-231, Darigabat, Tavapadon, CVL-871, and CVL-936. The company was founded in 2018 and is headquartered in Cambridge, MA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 673 is 41.60 EUR — it has increased by 0.97% in the past 24 hours. Watch CEREVEL THERAPEUTICS HOLDINGS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange CEREVEL THERAPEUTICS HOLDINGS INC stocks are traded under the ticker 673.
673 stock is 1.96% volatile and has beta coefficient of −0.63. Track CEREVEL THERAPEUTICS HOLDINGS INC stock price on the chart and check out the list of the most volatile stocks — is CEREVEL THERAPEUTICS HOLDINGS INC there?
Yes, you can track CEREVEL THERAPEUTICS HOLDINGS INC financials in yearly and quarterly reports right on TradingView.
CEREVEL THERAPEUTICS HOLDINGS INC is going to release the next earnings report on Nov 25, 2024. Keep track of upcoming events with our Earnings Calendar.
673 net income for the last quarter is −122.25 M EUR, while the quarter before that showed −120.19 M EUR of net income which accounts for −1.72% change. Track more CEREVEL THERAPEUTICS HOLDINGS INC financial stats to get the full picture.
No, 673 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 25, 2024, the company has 334.00 employees. See our rating of the largest employees — is CEREVEL THERAPEUTICS HOLDINGS INC on this list?
Like other stocks, 673 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CEREVEL THERAPEUTICS HOLDINGS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CEREVEL THERAPEUTICS HOLDINGS INC technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CEREVEL THERAPEUTICS HOLDINGS INC stock shows the strong buy signal. See more of CEREVEL THERAPEUTICS HOLDINGS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.